>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:
  • TMCI +28.3% (guidance), AXNX +21.3% (guidance), RXST +8.4% (guidance), AKYA +8.3% (guidance), CROX +7.8% (guidance), CALT +5.5% (guidance), ADMA +3.4% (guidance), BCRX +2.6% (guidance), BOOT +2.6% (guidance), EWCZ +2.3% (guidance), NUS +1.9% (guidance), TAST +1.7% (guidance), ANF +1.4% (guidance), RPRX +1.3% (guidance), CTRN +1.3% (guidance), OSW +0.9% (guidance), DXLG +0.8% (guidance), HELE +0.7%
Other news:
  • RLAY +8.9% (enters into $30 mln securities purchase agreement for private placement financing with Nextech to sell approximately 2.5 mln shares of common stock at $12.00 per share)
  • GLUE +8.5% (Provides Corporate Update and Key Anticipated Milestones for 2024)
  • MOLN +8.3% (Provides Updates at 42nd Annual J.P. Morgan Healthcare Conference)
  • LGND +5.9% (FDA has approved ZELSUVMI)
  • LYRA +4% (releases presentation with data on file as of January 5 2024 from the BEACON Phase 2 clinical trial demonstrating statistically significant improvement in loss of smell in a subset of patients with impaired smell at baseline)
  • ANNX +3.2% (Outlines 2024 Priorities with Late-Stage Clinical Milestones Across Upstream Complement Portfolio for Autoimmune Ophthalmic and Neurodegenerative Diseases)
  • HUT +3% (received an approval and vesting order related to previously announced stalking horse bid transaction)
  • CABA +2.7% (receives additional FDA Fast Track Designations for CABA-201 in dermatomyositis and systemic sclerosis)
  • RPTX +2.1% (provides corporate update and highlights anticipated key 2024 milestones)
  • LXRX +2% (provides business and pipeline update at 42nd Annual J.P. Morgan Healthcare Conference)
  • ABSI +1.9% (will be presenting positive preclinical data for ABS-101 a potential best-in-class anti-TL1A antibody program)
  • WRAP +1.4% (terminates CFO Chris DeAlmeida effective immediately)
  • ZURA +1.2% (appointments of Robert Lisicki as President and Chief Operating Officer)
  • QGEN +1% (receives FDA clearance of NeuMoDx CT/NG Assay for use on both NeuMoDx 96 and 288 Molecular Systems; announces plans to return ~$300 million to shareholders)
Analyst comments:
  • DASH +3.6% (upgraded to Buy from Hold at Jefferies)
  • DELL +2.6% (upgraded to Overweight from Neutral at JP Morgan)
  • AQN +2.5% (upgraded to Outperform from Market Perform at BMO Capital Markets)
  • EFX +1.3% (upgraded to Buy from Underperform at BofA Securities)
  • AON +1.1% (upgraded to Overweight from Neutral at JP Morgan)
  • BRO +1% (upgraded to Buy from Neutral at Goldman)
  • AAL +0.9% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
  • AMD +0.8% (upgraded to Buy from Hold at Melius)

>>> US Research Calls

Research Calls I
  • Upgrades:
    • Advanced Micro (AMD) upgraded to Buy from Hold at Melius
    • Algonquin Power & Utilities (AQN) upgraded to Outperform from Market Perform at BMO Capital Markets; tgt raised to $7.50
    • American Airlines (AAL) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt $20
    • Aon (AON) upgraded to Overweight from Neutral at JP Morgan; tgt lowered to $321
    • Beacon Roofing Supply (BECN) upgraded to Outperform from Mkt Perform at William Blair
    • Blink Charging (BLNK) upgraded to Buy from Hold at Needham; tgt $7
    • Brown & Brown (bRO) upgraded to Outperform from Sector Perform at RBC Capital Mkts; tgt $81
    • Brown & Brown (BRO) upgraded to Buy from Neutral at Goldman; tgt lowered to $83
    • Cboe Global Markets (CBOE) upgraded to Overweight from Equal Weight at Barclays; tgt raised to $204
    • Chevron (CVX) upgraded to Buy from Hold at Jefferies; tgt $184
    • Core & Main (CNM) upgraded to Buy from Neutral at Citigroup; tgt raised to $48
    • Dell (DELL) upgraded to Overweight from Neutral at JP Morgan; tgt raised to $90
    • DoorDash (DASH) upgraded to Buy from Hold at Jefferies; tgt raised to $130
    • Equifax (EFX) upgraded to Buy from Underperform at BofA Securities; tgt raised to $300
    • Eagle Materials (EXP) upgraded to Buy from Hold at Loop Capital; tgt raised to $240
    • Enphase Energy (ENPH) upgraded to Overweight from Equal Weight at Wells Fargo; tgt raised to $141
    • EPAM Systems (EPAM) upgraded to Buy from Hold at HSBC Securities
    • Fastly (FSLY) upgraded to Sector Perform from Underperform at RBC Capital Mkts; tgt raised to $18
    • FedEx (FDX) upgraded to Buy from Hold at Melius
    • Fiserv (FI) upgraded to Overweight from Sector Weight at KeyBanc Capital Markets; tgt $180
    • Franklin Resources (BEN) upgraded to Equal Weight from Underweight at Wells Fargo; tgt raised to $30
    • Freeport-McMoRan (FCX) upgraded to Outperform from Mkt Perform at Bernstein; tgt raised to $48.50
    • GitLab (GTLB) upgraded to Buy from Neutral at Mizuho; tgt $73
  • Downgrades:
    • Agilon Health (AGL) downgraded to Peer Perform from Outperform at Wolfe Research
    • Alaska Air (ALK) downgraded to Hold from Buy at Melius
    • American Express (AXP) downgraded to Underperform from Neutral at Robert W. Baird; tgt $190
    • Apple Hospitality REIT (APLE) downgraded to Neutral from Buy at BofA Securities; tgt lowered to $18
    • Ardagh Metal Packaging S.A. (AMBP) downgraded to Equal Weight from Overweight at Barclays; tgt $4
    • Array Tech (ARRY) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $19
    • Axalta Coating Systems (AXTA) downgraded to Neutral from Buy at UBS; tgt raised to $36
    • Barrick (GOLD) downgraded to Mkt Perform from Outperform at Bernstein
    • Cabot (CBT) downgraded to Neutral from Buy at UBS; tgt lowered to $87
    • Capital One (COF) downgraded to Neutral from Outperform at Robert W. Baird; tgt lowered to $145
    • Chubb (CB) downgraded to Neutral from Buy at Goldman; tgt $222
    • CME Group (CME) downgraded to Equal Weight from Overweight at Barclays; tgt lowered to $222
    • Exelon (EXC) downgraded to Neutral from Buy at Seaport Research Partners
    • Fabrinet (FN) downgraded to Neutral from Overweight at JP Morgan; tgt raised to $210
    • Ferguson plc (FERG) downgraded to Mkt Perform from Outperform at Raymond James
    • Fidelis Insurance Holdings Limited (FIHL) downgraded to Neutral from Overweight at JP Morgan; tgt lowered to $15
    • First Solar (FSLR) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $187
    • Fresenius Medical (FMS) downgraded to Underweight from Equal-Weight at Morgan Stanley
    • Garmin (GRMN) downgraded to Neutral from Overweight at JP Morgan; tgt $135
    • Southwest Air (LUV) downgraded to Underperform from Mkt Perform at Bernstein; tgt $24
  • Others:
    • Allison Transmission (ALSN) initiated with an Equal-Weight at Morgan Stanley; tgt $62
    • American Intl (AIG) resumed with a Neutral at JP Morgan; tgt $73
    • Aramark (ARMK) initiated with a Buy at Truist; tgt $33
    • CNH Industrial (CNHI) initiated with an Equal-Weight at Morgan Stanley
    • Complete Solaria (CSLR) initiated with an Overweight at Cantor Fitzgerald; tgt $6
    • Couchbase (BASE) initiated with an Overweight at Wells Fargo; tgt $26
    • Cummins (CMI) initiated with an Overweight at Morgan Stanley; tgt $278
    • Caterpillar (CAT) initiated with an Equal-Weight at Morgan Stanley; tgt $270
    • Deere (DE) initiated with an Overweight at Morgan Stanley; tgt $430
    • Donaldson (DCI) initiated with an Underweight at Morgan Stanley; tgt $59

>>> US Early premarket gappers

Early premarket gappers
  • Gapping up:
    • HARP +104%, ANNX +9.7%, AKYA +8.1%, MOLN +6.1%, LGND +5.9%, LYRA +4%, BOOT +3.9%, BCRX +3.3%, CALT +2.2%, RXST +2.1%, BEAM +2%, ALNY +1.8%, FOLD +1.7%, ZURA +1.2%, HUT +1.2%, QGEN +0.9%, WRAP +0.7%, NVS +0.6%, ASND +0.6%
  • Gapping down:
    • BA -8.5%, PRME -4.9%, ASLE -2.9%, CNM -2.9%, LULU -2.7%, TLYS -2.7%, LDI -2.2%, GTY -1.8%, CLSK -1.6%, HNST -1.4%, PMVP -1.1%, SHEL -1%, VRTX -0.8%, SAGE -0.8%

>>> Europe : Brokers Upgrades & Downgrades - 8th of January 2024 V3(++0

>>> Up
* Altarea Raised to Neutral at Oddo BHF; PT 87 euros (++)
* Amplifon Raised to Overweight at Morgan Stanley; PT 35 euros (+)
* ASML Raised to Buy at Kepler Cheuvreux; PT 770 euros (+)
* Bellway Raised to Overweight at Barclays; PT 3,022 pence
* CMC Markets Raised to Buy at Peel Hunt; PT 140 pence (++)
* Covivio Raised to Outperform at Oddo BHF; PT 58 euros (++)
* Crest Nicholson Raised to Overweight at Barclays; PT 258 pence
* Deutsche Euroshop Raised to Neutral at Oddo BHF; PT 23.50 euros (++)
* Elia Group Raised to Buy at Goldman; PT 135 euros
* Elia Group Raised to Outperform at BNPP Exane
* Elkem Raised to Buy at SpareBank; PT 26 kroner (+)
* Endesa Raised to Buy at Goldman; PT 24.50 euros
* Epiroc Raised to Buy at Pareto Securities; PT 215 kronor (+)
* Galp Cut to Underweight at Morgan Stanley; PT 12.80 euros
* Geberit Raised to Hold at HSBC; PT 481 Swiss francs
* HAL Raised to Hold at Bank Degroof Petercam; PT 114 euros (++)
* Legal & General Raised to Buy at Berenberg (+)
* Patrizia Raised to Outperform at Oddo BHF; PT 10 euros (++)
* Publicis Raised to Outperform at Macquarie
* Redeia Raised to Neutral at Goldman; PT 16 euros
* Scatec Raised to Hold at DNB Markets; PT 70 kroner
* Societe Fonciere Lyonnaise Raised to Neutral at Oddo BHF (++)
* SoftwareONE Raised to Add at Baader Helvea; PT 18 Swiss francs
* Sonova Raised to Overweight at Morgan Stanley (+)
* Temenos Raised to Buy at Jefferies; PT 90 Swiss francs
* VGP Raised to Outperform at Oddo BHF; PT 125 euros (++)
* Warsaw Stock Exchange Raised to Buy at Wood & Company (+)
* Xior Raised to Outperform at Oddo BHF; PT 36 euros (++)

>>> Down
* Ashtead Cut to Hold at HSBC; PT 5,250 pence
* Aurubis Cut to Hold at Bankhaus Metzler (+)
* Barratt Cut to Equal-Weight at Barclays; PT 560 pence
* Barry Callebaut Cut to Hold at Kepler Cheuvreux
* Berkeley Cut to Equal-Weight at Barclays; PT 4,812 pence
* BE Semiconductor Cut to Reduce at Bank Degroof Petercam (++)
* Byggfakta Group Nordic Holdco Cut to Hold at Jefferies
* Citigroup Cut to Sell at SocGen; PT $43
* CMC Markets Cut to Add at Numis; PT 130 pence (+)
* Demant Cut to Underweight at Morgan Stanley; PT 255 kroner (+)
* EDP Renovaveis Cut to Neutral at Goldman; PT 19.50 euros
* EDP Renovaveis Cut to Neutral at BNPP Exane
* Elopak Cut to Neutral at BNPP Exane; PT 31 kroner (++)
* Equinor Cut to Underweight at Morgan Stanley; PT 264 kroner
* Endesa Cut to Underperform at BNPP Exane
* Exor Cut to Hold at Bank Degroof Petercam (++)
* Fortum Cut to Neutral at Goldman; PT 15.20 euros
* Fractal Gaming Group Cut to Hold at ABG; PT 39 kronor
* Fresenius Medical Care A Cut to Underweight at Morgan Stanley (+)
* Gecina Cut to Underweight at Morgan Stanley; PT 90 euros
* ICADE Cut to Neutral at Oddo BHF; PT 39 euros (++)
* Inmobiliaria Colonial Cut to Underweight at Morgan Stanley
* Kingspan Cut to Hold at HSBC; PT 83 euros
* Konecranes Cut to Hold at SEB Equities; PT 41 euros
* Mercialys Cut to Neutral at Oddo BHF; PT 10.80 euros (++)
* Merlin Properties Cut to Equal-Weight at Morgan Stanley
* Naturgy Cut to Underperform at BNPP Exane
* Prudential Cut to Hold at Daiwa; PT 910 pence
* QT Group Cut to Reduce at Inderes; PT 65 euros
* Rockwool Cut to Hold at HSBC; PT 2,200 kroner
* SEB Cut to Hold at Arctic Securities; PT 148 kronor
* Siemens Healthineers Cut to Hold at Jyske Bank; PT 56.50 euros
* Spectris Cut to Hold at HSBC; PT 4,200 pence
* Sweco Cut to Hold at SEB Equities; PT 130 kronor

>>> Initiation
* Italgas Rated New Outperform at BNPP Exane (+)
* SBE-Varvit-SpA Rated New Buy at Equita; PT 10.10 euros (+)
* Simone Rated New Buy at Integrae SIM; PT 3.10 euros (++)
* Snam Rated New Outperform at BNPP Exane (+)
* Terna Rated New Neutral at BNPP Exane (+)

>>> Call
* Bernstein Says European Stocks Are Yet to Reflect Soft Landing (++)
* IPhone Sales in China to Fall Double Digits, Jefferies Says
* Galp, Equinor Are Biggest Europe Laggards on Morgan Stanley Cuts (++)
* Goldman Sees Potential Upside to Its S&P 500 Earnings Forecast
* Morgan Stanley Sees Stocks Stalling Till Growth Re-Accelerates (+)

Sunday Times : As London waits for a boom, which companies could be takeover ta

As London waits for a boom, which companies could be takeover targets?
Wars, inflation and high interest rates killed takeovers in 2023, but bankers believe buyers and sellers were simply biding their time — and the rainmakers will be back as the economy improves

It is not uncommon for the cafés and restaurants in the Square Mile to struggle in the first week of January as the City’s high-rolling dealmakers snub London’s grey skies in favour of the ski chalets of Courchevel.

This week, however, London’s rainmakers are back. And after a dismal 2023, there is plenty to be optimistic about, according to one of the UK’s top investment bankers: “People will be waking up with a little more spring in their step.”

Global company takeovers — the fuel of the City’s money-generating engine — sank last year as concerns over the Ukraine war, soaring inflation, rising interest rates and weak consumer sentiment stymied mergers and acquisitions (M&As).


The value of deals last year totalled $2.9 trillion (£2.3 trillion), down from $3.6 trillion in 2022 and $5.3 trillion in 2021, according to the London Stock Exchange Group. You have to go back to 2014 to find a year when deal values were lower.

However, while the world’s economic woes are far from over, bankers insist that dialogue between buyers and sellers continued even during last year’s M&A malaise. The problem was getting all parties to agree on price, said Stephan Feldgoise, co-head of global M&A at Goldman Sachs.

But now, amid hopes that the worst of the inflationary pressures are over and that central banks will this year begin cutting interest rates, M&As could have the wind in their sails, according to Kirshlen Moodley, UK head of advisory at BNP Paribas.

And, he said, with City movers and shakers grumbling that UK companies appear cheap compared with their counterparts overseas, Britain may indeed be “up for sale”.

Christopher Jones, managing partner at Clearwater International, said: “There is a huge backlog of assets that are being readied for sale in 2024 — our sellside pipeline is by far the largest it has ever been. In many instances the owners of these assets have put their plans on hold for four or five years and can’t /won’t wait forever. There are a great many private equity-owned assets that were bought 2015-18 and are now long in the tooth. The investors need to exit as the funds the assets sit in are being run off, and after so many years management teams need to catalyse succession and create liquidity.”

There are also reasons to be optimistic about the public markets. Moodley said that the cost of debt may start to come down and that this, combined with a more stable economic outlook, will allow suitors for listed companies to make higher offers that are hard to refuse.

“When we talk to clients, they want to start doing things,” said one senior investment banker.

Moodley pointed out that activist investors will be alive to this and could pile fresh pressure on City boards to sell.

Private equity has already made its intentions felt. Take Apollo Global Management’s £500 million take-out of The Restaurant Group, the London-listed company behind Wagamama. Not only did the Wall Street fund provide the equity for the deal last autumn, but it took on more than £100 million of the debt alongside Royal Bank of Canada in a “hybrid” deal.

In other words, if private equity cannot find the banks to offer the lending, they are increasingly likely to provide it themselves.

“I think you will see more of that. There are enough hybrid funds out there,” said one banker.
Some American bankers, such as Feldgoise at Goldman Sachs, are convinced that the gloomy 2023 was an outlier.

“If you look at M&A as a percentage of GDP, which is a common statistic, it’s been running 2 to 3, maybe 3.5, per cent over the last year,” Feldgoise said last week. “If you look back over 20 or 25 years, it generally runs in the 5 per cent range.”

The City commuters returning from their New Year jaunts this week will be hoping that this optimistic view holds true.

Which British stocks might be targets?
Analysts at Quest, owned by investment bank Canaccord Genuity, have come up with a way of rating stocks based on how dealmakers would look at a company. Their method works out how much of a financial return you could make from a business based on its cashflow, factoring in the cost of acquiring it.

Here are some of their top picks among the FTSE’s larger companies.

Centrica
The British Gas owner has had a strong 12 months, with its shares surging by nearly 65 per cent on buoyant energy prices. In recent years, it has restructured and strengthened its balance sheet, leaving it the tricky problem of where to invest its excess cash.

Quest reckons Centrica is severely undervalued, in part because it is generating so much cash.
Last month, indeed, analysts at UBS noted that the company could have up to £1.9 billion of spare liquidity to deploy this year, on top of what it has set aside for share buybacks and other growth projects. Precisely because of its strong cash position, Quest also puts Centrica top of the list of potential large-cap acquirers in the sector.

Harbour Energy
The North Sea oil and gas company was clobbered by the government windfall tax last year, so has set its sights on expanding beyond the UK. Last month, it announced the $11 billion takeover of Wintershall Dea, which could double the size of the company. Wintershall, a German-based rival, has assets in Norway, Argentina and Mexico.
Quest analysts reckon Harbour itself could be a tasty target, even before that deal completes. As well as funding $2.1 billion of the deal from its own cashflow, Harbour has paid out $440 million in dividends in the past year, and has said it could be debt free in 2024.

Easyjet
Airlines are often a hard sell for dealmakers. Pinning a valuation on a business that is so dependent on oil prices — a cost largely outside management’s control — is no mean feat. Nevertheless, speculation has swirled for some time that easyJet is vulnerable to a takeover attempt, even though the company’s share price rose by a third last year.

Despite this resurgence and its recent posting of record annual profits, the company looks cheap compared with competitors such as Ryanair. This — plus the fact that easyJet owns lots of valuable assets, such as its aircraft — puts the Luton-based carrier at number three on Quest’s list of big-ticket takeover targets.

Indivior
In some ways, Indivior sits awkwardly on the FTSE. In previous years, the pharmaceutical company, which was spun out from consumer giant Reckitt Benckiser in 2014 and makes treatments for opioid abuse, has made about 80 per cent of its revenues in the US. Last summer, Indivior took the plunge and crossed the Atlantic, taking a secondary listing on the Nasdaq exchange.
Since the dual listing, the shares have fallen by about 30 per cent on both the London and New York markets. In its last set of results, Indivior reported a 21 per cent jump in revenue.

Serco
Serco’s history on the London market has not been without turbulence. The outsourcing giant provides everything from asylum accommodation to security services, but found itself in freefall about a decade ago, when it was found to have overcharged the government for its services.

Its share price, which is three per cent up on last year, has never fully recovered from the subsequent dive, making it attractive for private equity barons. And the business has also gone through a major shake-up, disposing of scores of peripheral divisions, making it a more focused operation. Its full-year results last month also showed that it made £170 million in free cash flow, around £20 million higher than previously expected.

Wise
Formerly known as TransferWise, this fintech is designed to send money hassle-free across borders. Its shares have risen steadily since it listed on the London Stock Exchange in 2021, making Wise one of the few bona fide float successes of recent years. It reported half-year revenues of £500 million in November, and free cashflow nearly half that, on a customer base that is growing at a rate of 30 per cent a year. Wise has also been helped by rising interest rates.

Drax
The Selby-based power generation company started life in the 1970s as a coal -fired power station. Now, the green transition may hold hopes for its future. Drax makes electricity from biomass, crushed wooden pellets that can be burned instead of fossil fuel.

The company also has a trading business through which it sells its power. The past year has proven fruitful for the company: in December it announced £1.2 billion in earnings before interest and tax, broadly in line with what it expected. Debate continues to rage about whether it provides truly green energy or not, but the company insists it is well placed to benefit from the energy transition, and that the government recognises the benefits of biomass.

Balfour Beatty
The construction sector had little to cheer last year after Rishi Sunak axed HS2, the country’s biggest infrastructure project and major gravy train for the sector. Balfour Beatty, the FTSE-250 construction giant, has kept up a steady drumbeat of work, however. Annual revenues rose 5 per cent in part thanks to international projects such as Hong Kong airport. Net cash each month last year was about £700 million. With the windfall in the bank, the company is gearing up for a share buyback programme.

Sunday Times :

As London waits for a boom, which companies could be takeover targets?
Wars, inflation and high interest rates killed takeovers in 2023, but bankers believe buyers and sellers were simply biding their time — and the rainmakers will be back as the economy improves

It is not uncommon for the cafés and restaurants in the Square Mile to struggle in the first week of January as the City’s high-rolling dealmakers snub London’s grey skies in favour of the ski chalets of Courchevel.

This week, however, London’s rainmakers are back. And after a dismal 2023, there is plenty to be optimistic about, according to one of the UK’s top investment bankers: “People will be waking up with a little more spring in their step.”

Global company takeovers — the fuel of the City’s money-generating engine — sank last year as concerns over the Ukraine war, soaring inflation, rising interest rates and weak consumer sentiment stymied mergers and acquisitions (M&As).


The value of deals last year totalled $2.9 trillion (£2.3 trillion), down from $3.6 trillion in 2022 and $5.3 trillion in 2021, according to the London Stock Exchange Group. You have to go back to 2014 to find a year when deal values were lower.

However, while the world’s economic woes are far from over, bankers insist that dialogue between buyers and sellers continued even during last year’s M&A malaise. The problem was getting all parties to agree on price, said Stephan Feldgoise, co-head of global M&A at Goldman Sachs.

But now, amid hopes that the worst of the inflationary pressures are over and that central banks will this year begin cutting interest rates, M&As could have the wind in their sails, according to Kirshlen Moodley, UK head of advisory at BNP Paribas.

And, he said, with City movers and shakers grumbling that UK companies appear cheap compared with their counterparts overseas, Britain may indeed be “up for sale”.

Christopher Jones, managing partner at Clearwater International, said: “There is a huge backlog of assets that are being readied for sale in 2024 — our sellside pipeline is by far the largest it has ever been. In many instances the owners of these assets have put their plans on hold for four or five years and can’t /won’t wait forever. There are a great many private equity-owned assets that were bought 2015-18 and are now long in the tooth. The investors need to exit as the funds the assets sit in are being run off, and after so many years management teams need to catalyse succession and create liquidity.”

There are also reasons to be optimistic about the public markets. Moodley said that the cost of debt may start to come down and that this, combined with a more stable economic outlook, will allow suitors for listed companies to make higher offers that are hard to refuse.

“When we talk to clients, they want to start doing things,” said one senior investment banker.

Moodley pointed out that activist investors will be alive to this and could pile fresh pressure on City boards to sell.

Private equity has already made its intentions felt. Take Apollo Global Management’s £500 million take-out of The Restaurant Group, the London-listed company behind Wagamama. Not only did the Wall Street fund provide the equity for the deal last autumn, but it took on more than £100 million of the debt alongside Royal Bank of Canada in a “hybrid” deal.

In other words, if private equity cannot find the banks to offer the lending, they are increasingly likely to provide it themselves.

“I think you will see more of that. There are enough hybrid funds out there,” said one banker.
Some American bankers, such as Feldgoise at Goldman Sachs, are convinced that the gloomy 2023 was an outlier.

“If you look at M&A as a percentage of GDP, which is a common statistic, it’s been running 2 to 3, maybe 3.5, per cent over the last year,” Feldgoise said last week. “If you look back over 20 or 25 years, it generally runs in the 5 per cent range.”

The City commuters returning from their New Year jaunts this week will be hoping that this optimistic view holds true.

Which British stocks might be targets?
Analysts at Quest, owned by investment bank Canaccord Genuity, have come up with a way of rating stocks based on how dealmakers would look at a company. Their method works out how much of a financial return you could make from a business based on its cashflow, factoring in the cost of acquiring it.

Here are some of their top picks among the FTSE’s larger companies.

Centrica
The British Gas owner has had a strong 12 months, with its shares surging by nearly 65 per cent on buoyant energy prices. In recent years, it has restructured and strengthened its balance sheet, leaving it the tricky problem of where to invest its excess cash.

Quest reckons Centrica is severely undervalued, in part because it is generating so much cash.
Last month, indeed, analysts at UBS noted that the company could have up to £1.9 billion of spare liquidity to deploy this year, on top of what it has set aside for share buybacks and other growth projects. Precisely because of its strong cash position, Quest also puts Centrica top of the list of potential large-cap acquirers in the sector.

Harbour Energy
The North Sea oil and gas company was clobbered by the government windfall tax last year, so has set its sights on expanding beyond the UK. Last month, it announced the $11 billion takeover of Wintershall Dea, which could double the size of the company. Wintershall, a German-based rival, has assets in Norway, Argentina and Mexico.
Quest analysts reckon Harbour itself could be a tasty target, even before that deal completes. As well as funding $2.1 billion of the deal from its own cashflow, Harbour has paid out $440 million in dividends in the past year, and has said it could be debt free in 2024.

Easyjet
Airlines are often a hard sell for dealmakers. Pinning a valuation on a business that is so dependent on oil prices — a cost largely outside management’s control — is no mean feat. Nevertheless, speculation has swirled for some time that easyJet is vulnerable to a takeover attempt, even though the company’s share price rose by a third last year.

Despite this resurgence and its recent posting of record annual profits, the company looks cheap compared with competitors such as Ryanair. This — plus the fact that easyJet owns lots of valuable assets, such as its aircraft — puts the Luton-based carrier at number three on Quest’s list of big-ticket takeover targets.

Indivior
In some ways, Indivior sits awkwardly on the FTSE. In previous years, the pharmaceutical company, which was spun out from consumer giant Reckitt Benckiser in 2014 and makes treatments for opioid abuse, has made about 80 per cent of its revenues in the US. Last summer, Indivior took the plunge and crossed the Atlantic, taking a secondary listing on the Nasdaq exchange.
Since the dual listing, the shares have fallen by about 30 per cent on both the London and New York markets. In its last set of results, Indivior reported a 21 per cent jump in revenue.

Serco
Serco’s history on the London market has not been without turbulence. The outsourcing giant provides everything from asylum accommodation to security services, but found itself in freefall about a decade ago, when it was found to have overcharged the government for its services.

Its share price, which is three per cent up on last year, has never fully recovered from the subsequent dive, making it attractive for private equity barons. And the business has also gone through a major shake-up, disposing of scores of peripheral divisions, making it a more focused operation. Its full-year results last month also showed that it made £170 million in free cash flow, around £20 million higher than previously expected.

Wise
Formerly known as TransferWise, this fintech is designed to send money hassle-free across borders. Its shares have risen steadily since it listed on the London Stock Exchange in 2021, making Wise one of the few bona fide float successes of recent years. It reported half-year revenues of £500 million in November, and free cashflow nearly half that, on a customer base that is growing at a rate of 30 per cent a year. Wise has also been helped by rising interest rates.

Drax
The Selby-based power generation company started life in the 1970s as a coal -fired power station. Now, the green transition may hold hopes for its future. Drax makes electricity from biomass, crushed wooden pellets that can be burned instead of fossil fuel.

The company also has a trading business through which it sells its power. The past year has proven fruitful for the company: in December it announced £1.2 billion in earnings before interest and tax, broadly in line with what it expected. Debate continues to rage about whether it provides truly green energy or not, but the company insists it is well placed to benefit from the energy transition, and that the government recognises the benefits of biomass.

Balfour Beatty
The construction sector had little to cheer last year after Rishi Sunak axed HS2, the country’s biggest infrastructure project and major gravy train for the sector. Balfour Beatty, the FTSE-250 construction giant, has kept up a steady drumbeat of work, however. Annual revenues rose 5 per cent in part thanks to international projects such as Hong Kong airport. Net cash each month last year was about £700 million. With the windfall in the bank, the company is gearing up for a share buyback programme.

>>> Europe : Brokers Upgrades & Downgrades - 8th of January 2024

>>> Up
* Amplifon Raised to Overweight at Morgan Stanley; PT 35 euros (+)
* ASML Raised to Buy at Kepler Cheuvreux; PT 770 euros (+)
* Bellway Raised to Overweight at Barclays; PT 3,022 pence
* Chevron Raised to Buy at Jefferies; PT $184
* Crest Nicholson Raised to Overweight at Barclays; PT 258 pence
* Elia Group Raised to Buy at Goldman; PT 135 euros
* Elia Group Raised to Outperform at BNPP Exane
* Elkem Raised to Buy at SpareBank; PT 26 kroner (+)
* Endesa Raised to Buy at Goldman; PT 24.50 euros
* Epiroc Raised to Buy at Pareto Securities; PT 215 kronor (+)
* Galp Cut to Underweight at Morgan Stanley; PT 12.80 euros
* Geberit Raised to Hold at HSBC; PT 481 Swiss francs
* Legal & General Raised to Buy at Berenberg (+)
* Publicis Raised to Outperform at Macquarie
* Redeia Raised to Neutral at Goldman; PT 16 euros
* Scatec Raised to Hold at DNB Markets; PT 70 kroner
* SoftwareONE Raised to Add at Baader Helvea; PT 18 Swiss francs
* Sonova Raised to Overweight at Morgan Stanley (+)
* Temenos Raised to Buy at Jefferies; PT 90 Swiss francs
* Warsaw Stock Exchange Raised to Buy at Wood & Company (+)

>>> Down
* Ashtead Cut to Hold at HSBC; PT 5,250 pence
* Aurubis Cut to Hold at Bankhaus Metzler (+)
* Barratt Cut to Equal-Weight at Barclays; PT 560 pence
* Barry Callebaut Cut to Hold at Kepler Cheuvreux
* Berkeley Cut to Equal-Weight at Barclays; PT 4,812 pence
* Byggfakta Group Nordic Holdco Cut to Hold at Jefferies
* Citigroup Cut to Sell at SocGen; PT $43
* CMC Markets Cut to Add at Numis; PT 130 pence (+)
* Demant Cut to Underweight at Morgan Stanley; PT 255 kroner (+)
* EDP Renovaveis Cut to Neutral at Goldman; PT 19.50 euros
* EDP Renovaveis Cut to Neutral at BNPP Exane
* Equinor Cut to Underweight at Morgan Stanley; PT 264 kroner
* Endesa Cut to Underperform at BNPP Exane
* Fortum Cut to Neutral at Goldman; PT 15.20 euros
* Fractal Gaming Group Cut to Hold at ABG; PT 39 kronor
* Fresenius Medical Care A Cut to Underweight at Morgan Stanley (+)
* Gecina Cut to Underweight at Morgan Stanley; PT 90 euros
* Inmobiliaria Colonial Cut to Underweight at Morgan Stanley
* Kingspan Cut to Hold at HSBC; PT 83 euros
* Konecranes Cut to Hold at SEB Equities; PT 41 euros
* Merlin Properties Cut to Equal-Weight at Morgan Stanley
* Naturgy Cut to Underperform at BNPP Exane
* Prudential Cut to Hold at Daiwa; PT 910 pence
* QT Group Cut to Reduce at Inderes; PT 65 euros
* Rockwool Cut to Hold at HSBC; PT 2,200 kroner
* SEB Cut to Hold at Arctic Securities; PT 148 kronor
* Siemens Healthineers Cut to Hold at Jyske Bank; PT 56.50 euros
* Spectris Cut to Hold at HSBC; PT 4,200 pence
* Sweco Cut to Hold at SEB Equities; PT 130 kronor

>>> Initiation
* Italgas Rated New Outperform at BNPP Exane (+)
* SBE-Varvit-SpA Rated New Buy at Equita; PT 10.10 euros (+)
* Snam Rated New Outperform at BNPP Exane (+)
* Terna Rated New Neutral at BNPP Exane (+)

>>> Call
* IPhone Sales in China to Fall Double Digits, Jefferies Says
* Goldman Sees Potential Upside to Its S&P 500 Earnings Forecast
* Morgan Stanley Sees Stocks Stalling Till Growth Re-Accelerates (+)

>>> Stoxx 600 Pre-Market Indications

  • Pandora (3P7 TH) +7.1%
    • Pandora Beats Estimates With Soaring Christmas Jewelry Sales (1)
  • Carl Zeiss Meditec (AFX TH) +2.9%
  • DSM-Firmenich (ZX6 TH) +2.6%
    • DSM-Firmenich Makes Voluntary Cash Offer for DSM Shares
  • Airbus (AIR TH) +1.7%
    • Watch European, US Boeing Suppliers as Carriers Ground 737 Max
  • Diageo (GUI TH) +1.6%
    • Diageo PLC DGE Transaction in Own Shares
  • Evotec SE (EVT TH) +1.4%
    • EQS-News: Evotec announces progress in strategic neuroscience partnership with Bristol Myers Squibb
  • Vodafone (VODI TH) +1%
    • Italian M&A Push Needs Iliad to Deliver Consolidation Benefits
  • Tomra (TMRA TH) +0.9%
  • Endesa (ENA TH) +0.8%
    • Endesa Cut to Underperform at BNPP Exane
  • BAT (BMT TH) +0.7%
  • Knorr-Bremse (KBX TH) -1.2%
  • Safran (SEJ1 TH) -1.3%
  • Naturgy (GAN TH) -1.3%
    • Naturgy Cut to Underperform at BNPP Exane
  • TUI (TUI1 TH) -1.3%
  • Danone (BSN TH) -1.3%
  • K+S (SDF TH) -1.4%
  • Prosus (1TY TH) -1.5%
  • Adyen (1N8 TH) -1.6%
  • Mowi (PND TH) -1.8%
  • Fresenius Medical Care (FME TH) -2.4%
    • Fresenius Medical Care A Cut to Underweight at Morgan Stanley